A new paper entitled “Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals” has recently been published in the journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. This study led by the members of the AMYPAD consortium aimed to investigate the relationship between amyloid burden and subsequent cognitive decline in an initially cognitively unimpaired population. The authors showed that quantifying longitudinal and regional changes in amyloid beta can improve the prediction of cognitive functioning in initially cognitively unimpaired individuals. Congratulations to the authors! The paper can be read here: https://doi.org/10.1002/dad2.12216
The AMYPAD project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115952. The Joint Undertaking receives support from the European Union’s Horizon2020 research and innovation programme and EFPIA. This article reflects the author’s view and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
